TrialClinical therapeutics2013

Pharmacokinetic and pharmacodynamic properties of single- and multiple-dose of dapagliflozin, a selective inhibitor of SGLT2, in healthy Chinese subjects.

Li Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.